Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02120339 · ClinicalTrials.gov registry record · Phase 1
Carvedilol PAH A Pilot Study of Efficacy and Safety
A Phase 1 study, sponsored by University of Minnesota.
- Terminated
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT02120339 is a Phase 1 study that was terminated before completion, run by University of Minnesota. The registered enrollment target is 5 participants.
The verdict
NCT02120339, a Phase 1 study, was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
Estimate the effect of chronic beta-adrenergic receptor blockade with carvedilol on RV function in patients with PAH. Assess the safety and tolerability of chronic carvedilol therapy in patients with PAH
Interventions
- DRUG Carvedilol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02120339
The ClinicalTrials.gov registry entry for NCT02120339 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Carvedilol is the first listed.
NCT02120339 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02120339 about?
NCT02120339 is a clinical study titled "Carvedilol PAH A Pilot Study of Efficacy and Safety". Estimate the effect of chronic beta-adrenergic receptor blockade with carvedilol on RV function in patients with PAH. Assess the safety and tolerability of chronic carvedilol therapy in patients with PAH
What is the current status of trial NCT02120339?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2014-05. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02120339?
The interventions under investigation include: Carvedilol (DRUG).
Who is sponsoring clinical trial NCT02120339?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.